PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
64.48
+0.58 (0.90%)
At close: Oct 8, 2025, 4:00 PM EDT
65.76
+1.28 (1.99%)
After-hours: Oct 8, 2025, 6:58 PM EDT

PTC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
5,1223,4812,0802,7862,8164,164
Upgrade
Market Cap Growth
81.73%67.40%-25.35%-1.06%-32.38%40.68%
Upgrade
Enterprise Value
5,6074,9403,2533,6713,2074,102
Upgrade
Last Close Price
64.4845.1427.5638.1739.8361.03
Upgrade
PS Ratio
2.844.322.223.995.2310.94
Upgrade
PB Ratio
--3.17-2.54-8.031958.208.64
Upgrade
EV/Sales Ratio
3.186.123.475.255.9510.77
Upgrade
Debt / Equity Ratio
-12.03-2.25-2.72-4.21882.732.28
Upgrade
Asset Turnover
0.780.450.520.380.260.20
Upgrade
Inventory Turnover
16.9922.0227.9536.9733.1723.33
Upgrade
Quick Ratio
3.502.261.901.391.744.23
Upgrade
Current Ratio
3.622.352.021.711.874.44
Upgrade
Return on Equity (ROE)
-----216.75%-81.42%
Upgrade
Return on Assets (ROA)
23.81%-5.09%-12.13%-15.09%-11.30%-11.21%
Upgrade
Return on Capital (ROIC)
28.68%-6.59%-17.30%-23.05%-16.43%-17.15%
Upgrade
Earnings Yield
12.28%-10.44%-30.13%-20.06%-18.61%-10.52%
Upgrade
FCF Yield
13.62%-3.28%-8.98%-13.95%-9.93%-5.09%
Upgrade
Buyback Yield / Dilution
-7.58%-2.68%-4.33%-1.79%-6.72%-12.17%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q